As you may recall, on February 28, 2023, the Drug Enforcement Agency (DEA) proposed new rules, Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation, which eliminate the pandemic-era flexibilities for prescribing controlled substances via telehealth.
The DEA received more than 38,000 comments on its proposed rules. In order to consider all the comments, DEA announced today, May 9, 2023, it is extending its pandemic-era telehealth flexibilities through November 11, 2023.
We are continuing to monitor the progress of this DEA proposal and will share updates with you as they come in.
If you have any questions, please email Chris Crosser at gro.n1686155167ppaa@1686155167sirhc1686155167.
Association of Advanced Practice Psychiatric Nurses
Advancing your practice, your career, and our community.
Footer
Contact
Management Office
1800 James St, Ste 103
Bellingham, WA 98225
360-734-3166
gro.n1686155167ppaa@1686155167ofni1686155167
No providers are located in the AAPPN office.